Details for New Drug Application (NDA): 061739
✉ Email this page to a colleague
NDA 061739 describes GARAMYCIN, which is a drug marketed by Schering and is included in seven NDAs. Additional details are available on the GARAMYCIN profile page.
The generic ingredient in GARAMYCIN is gentamicin sulfate. There are fifteen drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the gentamicin sulfate profile page.
The generic ingredient in GARAMYCIN is gentamicin sulfate. There are fifteen drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the gentamicin sulfate profile page.
Summary for 061739
| Tradename: | GARAMYCIN |
| Applicant: | Schering |
| Ingredient: | gentamicin sulfate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 10MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
